New combo therapy aims to outsmart relapsed hodgkin lymphoma
Disease control
Not yet recruiting
This study tests a combination of the immunotherapy drug pembrolizumab and three chemotherapy drugs (GVD) in 38 adults with Hodgkin lymphoma that has come back or not responded to initial treatment. The goal is to see if this approach can make the cancer disappear completely, usi…
Phase: PHASE2 • Sponsor: Michael Spinner, MD • Aim: Disease control
Last updated Jun 17, 2026 05:55 UTC